Dermatophyte infections affect approximately one quarter of the global population. While these infections are not life-threatening, they can significantly impact quality of life. Recently, substantial changes in the epidemiology of dermatophyte infections have been observed worldwide, including increasing reports of antifungal resistance and the emergence of novel species causing extensive, often therapy-refractory disease. Since no local epidemiological data are available, this study aimed to examine the species distribution and antifungal susceptibility of dermatophytes isolated at the Department of Medical Microbiology.